Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study
Objectives To clarify non-alcoholic fatty liver disease (NAFLD) prevalence, risk factors and clinical outcome in an exemplary Chinese population, a cohort of company employees was followed up for 11 years.Design Retrospective cohort study.Setting Between 2006 and 2016 in Ning bo, China.Participants...
Main Authors: | Steven Dooley, Juan Du, Xiaoping Tang, Lan Chen, Jinzhu Jia, Fujun Li, Yanyan Shi, Christoph Meyer, Zhongwei Zhu, Yanming Zhang, Roman Liebe, Keming Hu, Tingting Zhou, Huier Zhang, Hong-Lei Weng, Tong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e054891.full |
Similar Items
-
Fatty alcohols /
by: 271542 Wilson, Glenn R. -
Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
by: Tim Hendrikx, et al.
Published: (2020-12-01) -
C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
by: Zhiwen Fan, et al.
Published: (2023-09-01) -
Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
by: Xinlu Cao, et al.
Published: (2023-07-01) -
S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
by: Xiaolin Liu, et al.
Published: (2015-01-01)